Search details
1.
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study.
Lancet Oncol
; 22(11): 1518-1529, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34634254
2.
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.
Lancet Oncol
; 17(1): 67-77, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26652797
3.
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine.
Hum Vaccin Immunother
; 19(3): 2289242, 2023 Dec 15.
Article
in English
| MEDLINE | ID: mdl-38078840
4.
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.
PLoS One
; 15(12): e0244242, 2020.
Article
in English
| MEDLINE | ID: mdl-33373380
5.
Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in India.
Papillomavirus Res
; 5: 163-171, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29578097
Results
1 -
5
de 5
1
Next >
>>